Gelin Biotech announced that the company initially publicly issued 333.33 million RMB common shares and was listed on the GEM. The issued shares accounted for 25.00% of the company's total share capital after issuance, and the total share capital after issuance was 133 million shares. The offering was carried out using a combination of strategic placement, offline distribution, and online distribution. The initial number of strategic placements was 10 million shares, 16.333,300 shares were initially distributed offline, and 7 million shares were initially issued online. The initial inquiry period for this sale is on August 14, 2026 at 9:30-15:00, and the online and offline subscription date is also August 20, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.